SACRAMENTO, Calif., Feb. 9, 2026 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, today announced the launch of a new oncology collaboration with a ...

Strong efficacy signals showing 33% ORR, 16.6-month PFS, and 27-month OS, improving on the SOC by 2-3X in a ...

Ohio State University researchers develop RNA micelles, offering targeted chemotherapy for metastatic colorectal cancer.

“Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint ...

FDA has accepted Exelixis' New Drug Application for zanzalintinib plus atezolizumab in previously treated metastatic colorectal cancer. The filing is supported by pivotal Phase 3 STELLAR-303 trial ...

Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells remain largely unknown. However, this is a crucial question for ...

Zanzalintinib is an investigational oral agent that inhibits tyrosine kinase receptors associated with cancer growth, including TYRO3, VEGF, MET, AXL, and MER.

Resection of liver metastases is considered the only treatment with curative potential for patients with metastatic colorectal cancer to the liver (CRLM). However, only a minority of patients with ...

Fashion influencer Dawn Roth has revealed she has been diagnosed with metastatic cancer that has spread to her colon, lungs, ...